The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer (Q36164034)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

neuroendocrinology

1 reference

based on heuristic

inferred from title

phaeochromocytoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

M Sue O'Dorisio

0 references

North American Neuroendocrine Tumor Society

7

object named as

North American Neuroendocrine Tumor Society (NANETS)

0 references

6

object named as

Karel Pacak

1 reference

Europe PubMed Central

12 August 2017

PMC publication ID

author name string

Herbert Chen

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Rebecca S Sippel

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M Sue O'Dorisio

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Aaron I Vinik

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Ricardo V Lloyd

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

North American Neuroendocrine Tumor Society (NANETS)

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

1 August 2010

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

39

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

775-783

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Current management of medullary thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Preoperative management of the pheochromocytoma patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Medullary thyroid cancer: therapeutic targets and molecular markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Phaeochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Functional imaging of endocrine tumors: role of positron emission tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

The role of human achaete-scute homolog-1 in medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma: the expanding genetic differential diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Biochemical diagnosis of pheochromocytoma: which test is best?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

The perioperative management of children with phaeochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Hereditary endocrinopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Clinical experience over 48 years with pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 July 2018

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Recent advances in the diagnosis and treatment of pheochromocytoma in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Extent of disease and practice patterns for medullary thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Utility of plasma free metanephrines for detecting childhood pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for Central and Bilateral Lymph Node Dissection in Sporadic and Hereditary Medullary Thyroid Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reoperation for recurrent or persistent medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical management of patients with persistent or recurrent medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hereditary medullary thyroid carcinoma in patients greater than 50 years old

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of pheochromocytoma in a 4- to 20-year-old population

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent genetic changes in childhood pheochromocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioguided parathyroidectomy in patients with familial hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is supine rest necessary before blood sampling for plasma metanephrines?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/MPA.0B013E3181EBB4F0

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

release_5sqdetvlmzgrdj3bbdmyi5j2we

1 reference

https://api.fatcat.wiki/v0/release/5sqdetvlmzgrdj3bbdmyi5j2we

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36164034&oldid=1977999685"